Lotus Apothecary Project Alleviate intends to reach a leading position in developing new drugs and vaccines on microbiological, viral, or biochemical basis, as well as products deriving from the theory of the Endobiont and the Ayurvedic medicine. Finally, the combination of modern biotechnology, the Endobiont and ancient natural medicine shall lead to innovative drug design and successful biological-medical therapies.

Dr. Pearl Laperla, the founder and CEO of the company and the GmbH affiliate in Munich, Germany, has studied and researched these theories for many years. She has achieved success in treatments. Essential components of the treatment are to balance the body's milieu and detoxify blood and the efficiency of milieu therapy is particularly crowned by an additional application of immuno-active products, like those are available in Lotus Apothecary Project Alleviate, GmbH. Under these circumstances, Dr. Laperla could not only reach alleviation of side effects, but even observe total curing of cancer disease like malignant melanoma, non-Hodgkin disease, prostate, marna, stomach cancer, leukemia, lung cancer, colon cancer, etc. She has experiences these results over more than ten years. In context of these therapies, Dr. Laperla has developed a unique dedicated diagnostic microscopic method to analyze human's blood, using the generally known darkfield microscopy. Her procedure and the know-how is hereby not only focused on the traditional components of the blood, but also specifically on Enderlein's Endobiont. It became one of Lotus Apothecary Project Alleviate's most important research and application fields to combine the modem biotechnology and molecular biology with the theories of Bechamp and Enderlein to develop new products and treatment systems to alleviate and cure diseases with high medical need, preferably in a natural biological way.

Further growth of Lotus Apothecary Project Alleviate is planned by the extension of the existing pilot plant of Lotus Apothecary Project Alleviate, GmbH in Germany. By this, the flexibility will be increased to incorporate additional biological product line either as own products or service offers to third parties. Starting with preparing the small quantities of sterile test samples in a pilot plant, under GMP conditions, Lotus Apothecary Project Alleviate shall extend its existing capacity in an effective, fast and safe way, to develop their own drugs and offer services for the third parties. These lines are related to viral, bacterial, biochemical and natural products. This will influence the capacity positively as every change of products requires a lot of time for cleaning and re-qualification. A special factor of growth should be the extension of the "Institute of Health Care" to get finally the approval for a private clinic to treat patients with high beneficial biological technologies. The company is actively providing Immune Modulator treatment services through the affiliated medical clinics in Munich, Germany to treat the patients from all over the world.

Lotus Apothecary Project Alleviate's biotechnology through various biological-medical applications will provide the advanced solutions to treat many diseases by improving our innate immune system and we believe that our treatment will also become essential keys to provide human well-being as well as prolong our longevity.